Dissemin is shutting down on January 1st, 2025

Published in

Elsevier, Acta Pharmaceutica Sinica B, 12(13), p. 4934-4944, 2023

DOI: 10.1016/j.apsb.2023.07.017

Links

Tools

Export citation

Search in Google Scholar

Discovery of a highly potent and orally available importin-β1 inhibitor that overcomes enzalutamide-resistance in advanced prostate cancer

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO